A new study published in the International Wound Journal highlights a striking parallel: the three-year recurrence rates for diabetic foot ulcers (DFU) and reintervention for chronic limb-threatening ischemia (CLTI) are comparable to—or exceed—those of advanced-stage cancers, including colorectal, breast, prostate, and even lung cancer.
Secure your spot and engage with a leading global network of clinicians, researchers, and innovators in diabetic foot care. Join 400+ high-quality medical professionals from across the globe—including leading podiatrists, vascular surgeons, cardiologists, endocrinologists, and wound care specialists—for three days of knowledge-sharing and collaboration.
In the groundbreaking BEST-CLI (Best Endovascular vs. Best Surgical Therapy in Patients with Critical Limb Ischemia) trial, a surprising and important observation emerged: female patients had fewer limb amputations than their male counterparts.
Dr. Katharine McGinigle, vascular surgeon-scientist and a board member of the American Limb Preservation Society (ALPS), led the gender-based secondary analysis of the trial. Here’s what they found:
Chongqing, Los Angeles — A landmark global study published today in Research (DOI: 10.34133/research.0702) projects a 220% increase in peripheral artery disease (PAD) cases worldwide by 2050, with prevalence expected to rise from 113 million in 2021 to more than 360 million.
The 3-Minute Diabetic Foot Exam is a powerful tool in the global fight against preventable amputations. In just three minutes, clinicians can identify critical warning signs and intervene early—potentially saving not just limbs, but lives. At the American Limb Preservation Society, we believe this simple, scalable exam belongs in every clinical setting.
Subscribe via email to get insights sent directly to your inbox.